IV. Nicht-epitheliale Malignome des Ovars

Literatur zum Abschnitt „Nicht-ephiteliale Malignome des Ovars“:
1. Bianco B., Lipay M.V., Melaragno M.I., Guedes A.D., Verreschi I.T. Detection of hidden Y mosaicism in Turner’s syndrome: importance in the prevention of gonadoblastoma. J Pediatr Endocrinol Metab 2006 Sep; 19(9):1113-7
2. Bridgewater J.A., Rustin G.J. Management of non-epithelial ovarian tumours. Oncology. 1999; 57(2):89-98
3. Brown J., Shvartsman H.S., Deavers M.T., Ramondetta L.M., Burke T.W., Munsell M.F., Gershenson D.M. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 2005 May; 97(2):489-96
4. Demidov V.N., Lipatenkova J., Vikhareva O., Van H.C., Timmerman D., Valentin L. Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig cell tumors. Ultrasound Obstet Gynecol 2008; 31:85-91
5. de Wit R., Louwerens M., de Mulder P.H., Verweij J., Rodenhuis S., Schornagel J. Management of intermediateprognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP. Int J Cancer 1999; 83(6):831-3
6. Freeman S.A., Modesitt S.C. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases. Gynecol Oncol 2006; 103(2):755-8
7. Hanigan M.H., Frierson H.F. Jr., Abeler V.M., Kaern J., Taylor P.T. Jr. Human germ cell tumours: expression of gammaglutamyl transpeptidase and sensitivity to cisplatin. Br J Cancer 1999; 81:75-79
8. Homesley H.D., Bundy B.N., Hurteau J.A., Roth L.M. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecol Oncol 1999; 72(2):131-7
9. Kauppila A., Bangah M., Burger H., Martikainen H. GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol 1992; 6(4):271-4
10. Kawai M., Kano T., Furuhashi Y., Mizuno K., Nakashima N., Hattori S.E. et al. Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases. Cancer 1991; 67(1):184-92
11. Kumar S., Shah J.P., Bryant C.S., Imudia A.N., Cote M.L., Ali-Fehmi R., Malone J.M. Jr., Morris R.T. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol 2008; 110(2):125-32
12. Lai C.H., Chang T.C., Hsueh S., Wu T.I., Chao A., Chou H.H. et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol 2005; 96(3):784-91
13. Lane A.H., Lee M.M., Fuller A.F. jr., Kehas D.J., Donahoe P.K., MacLaughlin D.T., Gynecol Oncol 1999 Apr; 73:51-5
14. McCluggage W.G., McKenna M., McBride H.A. CD 56 is a sensitive and diagnostically useful immunhistochemical marker of ovarian sex cord-stromal tumors. Int J Pathol 2007 Jul; 26:322-7
15. McHale M.T., DiSaia P.J. Fertility-sparing treatment of patients with ovarian cancer. Compr Ther 1999; 25:144-150
16. Mitchell P.L., Al-Nasiri N., A’Hern R., Fisher C., Horwich A., Pinkerton C.R. et al. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 1999; 85(10):2232-44
17. Mom C.H., Engelen M.J., Willemse P.H., Gietema J.A., ten Hoor K.A., de Vries E.G., van der Zee A.G. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol 2007 May; 105:365-72
18. Murugaesu N., Schmid P., Dancey G., Agarwal R., Holden L., McNeish I. et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 2006; 24(30):4862-6
19. Nawa A., Obata N., Kikkawa F., Kawai M., Nagasaka T., Goto S. et al. Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol 2001; 184(6):1182-8
20. Pectasides D., Pectasides E., Psyrri A. Granulosa cell tumor of the ovary. Cancer Treat Rev 2008; 34(1):1-12
21. Solh H.M., Azoury R.S., Najjar S.S. Peutz-Jeghers syndrome associated with precocious puberty. J Pediatr 1983; 103(4):593-5
22. Tamimi H.K., Bolen J.W. Enchondromatosis (Ollier’s disease) and ovarian juvenile granulosa cell tumor. Cancer 1984; 53(7):1605-8
23. Williams S.D., Blessing J.A., Liao S.Y., Ball H., Hanjani P. () Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 1994; 12:701-706
24. Tanaka Y., Sasaki Y., Nishihira H., Izawa T., Nishi T. Ovarian juvenile granulosa cell tumor associated with Maffucci’s syndrome. Am J Clin Pathol 1992; 97(4):523-7
25. Van Holsbeke C., Domali E., Holland T.K., Achten R., Testa A.C., Valentin L., Jurkovic D., Moerman P., Timmerman D. Imaging of gynecological disease (3): clinical and ultrasound characteristics of granulosa cell tumors of the ovary. Ultrasound Obstet Gynecol 2008; 31:450-456
26. Vihko K.K., Bläuer M., Puistola U., Tuohimaa P. Activin B in patients with granulosa cell tumors: serum levels in comparison to inhibin. Acta Obstet Gynecol Scand 2003; 82(6):570-4
27. Vlasak I., Plöchl E., Kronberger G., Bergendi E., Rittinger O., Hagemann M., Schmitt K., Blümel P., Glatzl J., Fekete G., Kadrnka-Lovrencic M., Borkenstein M., Häusler G., Frisch H. Screening of patients with Turner syndrome for „hidden“ Y-mosaicism. Klin Padiatr 1999; 211(1):30-4
28. Widschwendter M., Meduri G., Loosfelt H., Schröcksnadel H., Hittmair A., Müller-Holzner E., Zeimet A.G. Fulminant recurrence of a Sertoli-Leydig cell tumour during pregnancy. Br J Obstet Gynaecol 1999; 106(3):284-5